🔎 Trials Near Me

Akèy › Myelom Miltip › Arkansas

Etid klinik pou Myelom Miltip nan Arkansas

9 etid pou Myelom Miltip ap chèche patisipan nan sit nan Arkansas.

Vil nan Arkansas

Tèks ofisyèl etid la (Anglè)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Highlands Oncology Group, Springdale
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07518186

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04634552

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04566328

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Highlands Oncology Group - Springdale /ID# 267742, Springdale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
  • University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Jun 10, 2026 · NCT05561387

Limited-duration Teclistamab

  • University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2025 · NCT05932680

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.